Genitourinary Cancer

Latest News

Person acute kidney injury Comprehensive image overview of kidneys showing sudden loss of function | Image Credit: © Premium Graphics - stock.adobe.com.
Opinion: Novel Risk Assessment Tool Helps Predict Cisplatin-Induced Acute Kidney Injury

July 24th 2024

Oncology nurses can utilize risk assessment to predict patients at increased risk for cisplatin-induced acute kidney injury.

Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors
Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors

July 22nd 2024

Enzalutamide Improves Undetectable PSA Levels in Nonmetastatic CSPC
Enzalutamide Improves Undetectable PSA Levels in Nonmetastatic CSPC

May 17th 2024

Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes vs Chemo in Urothelial Cancer
Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes vs Chemo in Urothelial Cancer

April 20th 2024

Radiation Method Has ‘Excellent Oncological Outcomes’ in RCC
Radiation Method Has ‘Excellent Oncological Outcomes’ in RCC

March 28th 2024

Video Interviews
Podcasts
Oncology Nursing News
Key Advances in Cancer Survivorship Toxicity Management
Carbone Cancer Center Expert Shares Biggest Updates in Kidney Cancer Treatment
Latest CME Events & Activities

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

December 6, 2024

Register Now!

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

More News

© 2024 MJH Life Sciences

All rights reserved.